1Parkin DM,Bray F,Ferlay J,et al. Global cancer statistics[J]. CA Cancer J Clin,2005;55(2):74.
2Wang YG,Chen KX,Wu GL,et al. An analysis: colon cancer mortality in Tianjin, China, from 1981 to 2000 [J].World J Gastroenterol, 2005 ; 11 (6) : 895.
3Jansson EA, Are A, Greicius G, et al. The Wnt/β-catenin signaling pathway targets PPARτ activity in colon cancer cells[J]. Proc Natl Acad Sci, 2005 ; 102(5) : 1460.
4Laken SJ,Petersen GM,Gruber SB,et al. Familial colorectal cancer in ashkenazim due to a hypermutable tract in APC [J].Nat Genet, 1997 ; 17(1) :79.
5Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool:feasibility of a multitarget assay panel [J].Gastroenterology , 2000 ;119(5): 1219.
6Qiu H,Sirivongs P,Rothenberger M,et al. Molecular prognostic factors in rectal cancer treated by radiation and surgery[J]. Dis Colon Rectum, 2000 ; 43(4): 451.
7Edler D, HaUstrom M, Johnston PG, et al. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer[J]. Clin Cancer Res, 2000;6(4):1378.
8Elsaleh H, Joseph D,Grien F,et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer [J]. Lancet, 2000 ; 355 (9217) : 1745.
9Harmon KE,Ryan JA,Biehl TR,et al.Benefits and safety of hepatic resection for colorectal metastases[J].Am J Surg,1999,177(5):402.
10Alberts SR,Horvath WL,Sternfeld WC,et al.Oxaliplatin,fluorouracil,and leucovorin for patients with unresectable liver-only metastases from colorectal cancer:a North Central Cancer Treatment Group phase II study[J].J Clin Oncol,2005,23(26):9243.
